Stock Research: Kissei Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Kissei Pharmaceutical

TSE:4547 JP3240600001
90
  • Value
    94
  • Growth
    48
  • Safety
    Safety
    78
  • Combined
    92
  • Sentiment
    47
  • 360° View
    360° View
    90
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceutical products. Its main businesses include the collection and analysis of medicine development information, manufacture and sale of medicines, purchase and sale of related materials, system development, construction contract work, facility management, and insurance agency business. It primarily operates in Japan. In the last fiscal year, the company had 1778 employees, a market cap of $1308 million, profits of $294 million, and revenue of $589 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 90 (better than 90% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Kissei Pharmaceutical are very positive. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Kissei Pharmaceutical. The consolidated Value Rank has an attractive rank of 78, which means that the share price of Kissei Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 78% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 94. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 47. Professional investors are more confident in 53% other stocks. The consolidated Growth Rank also has a low rank of 48, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 52 of its competitors have better growth. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
78 76 86 85
Growth
48 51 35 19
Safety
Safety
94 92 65 94
Sentiment
47 32 10 44
360° View
360° View
90 81 45 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
51 17 35 78
Opinions Change
95 28 6 96
Pro Holdings
n/a 80 44 12
Market Pulse
14 44 7 3
Sentiment
47 32 10 44
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
78 76 86 85
Growth
48 51 35 19
Safety Safety
94 92 65 94
Combined
92 98 77 78
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
70 56 86 47
Price vs. Earnings (P/E)
42 48 55 72
Price vs. Book (P/B)
86 95 78 100
Dividend Yield
74 63 78 88
Value
78 76 86 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
16 11 33 67
Profit Growth
44 32 42 11
Capital Growth
42 82 7 1
Stock Returns
90 78 87 71
Growth
48 51 35 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
89 91 85 82
Refinancing
80 83 89 91
Liquidity
84 76 4 61
Safety Safety
94 92 65 94

Similar Stocks

Discover high‑ranked alternatives to Kissei Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Daiwabo Holdings

TSE:3107
Country: Japan
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Isuzu Motors

TSE:7202
Country: Japan
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Hisamitsu Pharmaceutical

TSE:4530
Country: Japan
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.